Review of The Use of 5-Fluorouracil as a Chemotherapy Drug to Treat Colorectal Adenocarcinoma
dc.contributor.author | Cincotta, Melissa | |
dc.contributor.author | Wanits, Lyndsey | |
dc.contributor.author | Whittaker, Jeremy | |
dc.date.accessioned | 2017-05-03T18:28:48Z | |
dc.date.available | 2017-05-03T18:28:48Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://hdl.handle.net/1951/69154 | |
dc.description | Colorectal Adenocarcinoma is a cancer isolated in the colon and rectum. It is the third most commonly diagnosed cancer in the United States[14].This cancer does not occur suddenly as it takes years to develop and tends to be caused by changes to the lining of the colon or rectum [4]. The p53 protein, that regulates the cell cycle to prevent mutations, is most commonly effected by colorectal adenocarcinoma by causing mismatch DNA repair sequence. [3] | en_US |
dc.language.iso | en_US | en_US |
dc.title | Review of The Use of 5-Fluorouracil as a Chemotherapy Drug to Treat Colorectal Adenocarcinoma | en_US |
dc.type | Learning Object | en_US |
dc.type | Presentation | en_US |
Files in this item
This item appears in the following Collection(s)
-
Student Research Showcase - April 12th and 13th, 2017 [12]
The Student Research Showcase aims to highlight the accomplished and talented scholarly work and research of SUNY Cobleskill students.